Pharmacokinetics of a F(ab′)2 scorpion antivenom administered intramuscularly in healthy human volunteers

International Immunopharmacology

Volumn 10, Issue 11, 2010, Pages 1318-1324

  Vázquez, Hilda ^a,b   Chávez Haro, Alfredo ^c   García Ubbelohde, Walter ^a   Paniagua Solís, Jorge ^a,b   Alagón, Alejandro ^d   Sevcik, Carlos ^e  

^a Laboratorios Silanes SA de CV   (Mexico)

^b Instituto Bioclón   (Mexico)

^c Mexican Red Cross   (Mexico)

^d INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^e INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Centruroides; Human; Intramuscular; Pharmacokinetics

Indexed keywords

ALACRAMYN; ANASCORP; IMMUNOGLOBULIN F(AB) FRAGMENT; UNCLASSIFIED DRUG; VENOM ANTISERUM;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCORPION; VOLUNTEER;

EID: 77958151730     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.08.018     Document Type: Article

References (31)

1. Norma Oficial Mexicana NOM-033-SSA2-2002. Para la vigilancia, prevención y control de la picadura de alacrán. Secretaría de Salud, México.
2. 2, IgG and IgG(T) fragments from hyper immune equine plasma. Int Immunopharmacol 2010, 10:447-454.
3. Isbister G. Failure of intramuscular antivenom in Red-back spider envenoming. Emerg Med 2002, 14:436-439.
4. Chaves F., Loría G.D., Salazar A., Gutiérrez J.M. Intramuscular administration of antivenoms in experimental envenomation by Bothrops asper: comparison between Fab and IgG. Toxicon 2003, 41:237-244.
5. Agarwal R., Aggarwal A.N., Gupta D., Behera D., Jindal S.K. Low dose of snake antivenom is as effective as high dose in patients with severe snake envenoming. Emerg Med J 2005, 22:397-399.
6. Ellis R.M., Sprivulis P.C., Jelinek G.A., Banham N.D.G., Wood S.V., Wilkes G.J., et al. A double-blind, randomized trial of intravenous versus intramuscular antivenom for Red-back spider envenoming. Emerg Med Aust 2005, 17:152-156.
7. Isbister G.K., O'Leary M., Miller M., Brown S.G.A., Ramasamy S., James R., et al. A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom. Br J Clin Pharmacol 2007, 65:139-143.
8. Isbister G.K., Brown S.G.A., Miller M., Tankel A., MacDonald E., Stokes B., et al. A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism-the RAVE study. Q J Med 2008, 101:557-565.
9. 2 scorpion antivenom in healthy human volunteers. Toxicon 2005, 46:797-805.
10. López de Silanes, J., Mancilla-Nava, R., Paniagua-Solís., J.F. Pharmaceutical composition of F(ab')2 antibody fragments. Patent No. PCT/MX05/000071. Instituto Bioclon, S.A. de C.V., Mexico, 2004. Freely available from http://www.freepatentsonline.com/7485303.html?query=PN/US7485303%2520OR%2520US7485303&stemming=on.
11. Osnaya-Romero N., Medina-Hernández T., de J., Flores-Hernández S.S., León-Rojas G. Clinical symptoms observed in children envenomed by scorpion stings, at children's hospital from the State of Morelos, Mexico. Toxicon 2001, 39:781-785.
12. Hollander M., Wolfe D.A. Nonparametric statistical procedures 1973, Wiley, New York.
13. Von Behring E.A., Kitasato S. Über das zustandeommen der diphterieimmunität und der tetanusimmunität bei thieren. Dtsch Med Wochenschr 1890, 16:1113-1134.
14. Klemperer F. Über natürliche Immunität und ihre Verwertung für die Immunisierungstherapie. Arch Exp Pathol Pharmakol 1893, 31:356-382.
15. Calmette A. Propriétés du sérum des animaux immunisés contre le venin des serpents et thérapeutique de l'envenimation. CR Acad Sci 1894, 68:720-722.
16. Dehesa-Davila M. Epidemiological characteristics of scorpion sting in Leon, Guanajuato, Mexico. Toxicon 1989, 27:281-286.
17. Dehesa-Davila M., Possani L.D. Scorpionism and serotherapy in Mexico. Toxicon 1994, 32:1015-1018.
18. Rahav G., Weiss T. Scorpion sting induced pulmonary edema. Chest 1990, 97:1478-1480.
19. Mathur A., Verma G., Gehlot R.S., Ujjwal J.S. Non cardiac pulmonary edema in scorpion bite. J Assoc Physicians India 1993, 41:398.
20. D'Suze G., Comellas A., Pesce L., Sevcik C., Sanchez-de-León R. Tityus discrepans venom produces a respiratory distress syndrome in rabbits through an indirect mechanism. Toxicon 1999, 37:173-180.
21. The Merck Manuals On Line Medical Library. http://www.merck.com/mmhe/index.html.
22. 2 extrusion mechanism from blood to tissues. Toxicon 2004, 44:731-734.
23. 2 antivenoms and other drugs. Toxicon 2007, 50:653-665.
24. Waldmann T.A. Immunotherapy: past, present and future. Nat Med 2003, 9:269-277.
25. D'Argenio D.Z., Schumitzky A. ADAPT II User's guide: pharmacokinetic/pharmacodynamic systems analysis software 1997, Biomedical Simulations Resouce, Los Angeles.
26. Nelder J., Mead R. A simplex method for function minimization. Comput J 1965, 7:308-313.
27. Hindmarsh A.C. Large ordinary differential equation systems and software. IEEE Control Syst Mag 1982, 2:24-30.
28. Petzold L.R. Automatic selection of methods for solving stiff and nonstiff systems of ordinary differential equations. SIAM J Sci Stat Comput 1983, 4:136-148.
29. D'Argenio D.Z., Schumitzky A., Wolf W. Simulation of linear compartment models with application to nuclear medicine kinetic modelling. Comput Meth Programs Biomed 1988, 27:47-54.
30. Carnahan B., Luther H.A., Wilkes J.O. Applied numerical methods 1969, Wiley, New York, Chapter 6.
31. Blode H., Brett M., Bührens K.G., Cawello W., Frick A., Gieschke R., et al. Collection of terms, symbols, equations, and explanations of common pharmacokinetic and pharmacodynamic parameters and some statistical functions. AGAH Working group on PK-PD modeling 2004, http: www.agah.infouploadsmediaPK-glo-ssary_PK_working_group_2004_01.pdf. B. Pechstein, W. Cawello (Eds.).